Functionally, these differences in context help to explain the clinical and biological differences in cancers that contain the same driver mutation (e.g., the diverse cancers with mutations in PDE11A or with those with mutations in CREB/ATF/CREM). This evidence concerns the gene CREB1 and cancer.